Position in OCGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$17,503,045
+$12,131,749 QoQ
Shares Held
9,670,191
+143.0% QoQ
Ownership
2.86%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 12%
Shared 0%
None 88%
Common Shares in OCGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026STATE STREET CORP holds $28,945,467,853 across 423 Biotechnology names. OCGN ranks #149 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,730,139 | $5,237,976,269 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,664,478 | $3,603,962,281 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,322,698 | $1,099,381,087 | |
| 4 | INSM |
INSMED Inc
|
5,551,699 | $907,813,820 | |
| 5 | INCY |
Incyte Corp
|
9,641,384 | $907,447,062 | |
| 6 | MRNA |
Moderna, Inc.
|
14,861,409 | $754,959,577 | |
| 7 | RPRX |
Royalty Pharma plc
|
10,989,851 | $527,183,152 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
16,186,613 | $448,369,180 |
All Filings in OCGN
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $17,503,045 | 9,670,191 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $5,371,296 | 3,978,738 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $2,209,264 | 1,355,377 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,298,751 | 1,338,919 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $4,188,020 | 5,932,041 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $4,722,216 | 5,866,108 | Shares | Defined | 2025-02-14 | |
| 2024-12-31 | $4,722,216 | 5,866,108 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $15,697,920 | 15,824,517 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $22,903,762 | 14,776,621 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,569,030 | 956,726 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $480,599 | 835,826 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $352,650 | 881,626 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $478,722 | 881,626 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $5,215,336 | 6,114,111 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $39,157,331 | 30,121,024 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $46,292,819 | 26,007,202 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $69,502,737 | 30,617,946 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $96,207,223 | 29,153,704 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $63,780,166 | 14,017,619 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $81,259,764 | 11,317,516 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $87,173,439 | 10,855,970 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $34,180,418 | 5,033,935 | Shares | Defined | 2021-07-09 | |
| 2020-12-31 | $18,849 | 10,300 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||